Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Explore year-end ETF Tax-Loss Harvesting ideas to harvest losses before year-end, diversify replacements, and sharpen tax efficiency.
25,086 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Rising fuel prices could ripple across daily expenses, lifting costs for groceries, transport, and services. This rep...
Delta Air Lines posted a notable weekly gain, with delta stock 9.38% this week, even as retail social chatter turned ...
Target’s dividend king status remains intact for now, but a cash flow squeeze and higher capex raise questions for in...
Chewy rode a brighter sales outlook to a rally in its stock, with the company signaling durable demand for pet care d...
Oil traders are weighing a hypothetical '$200 trump radar' scenario as prices approach extreme levels. This report ex...
A standout AI infrastructure stock is delivering blistering earnings growth in 2026, reshaping the investing landscap...
Oil sits near the $100 mark on May 7, 2026, with Brent at 100.45 per barrel at 8:45 a.m. ET. The day’s move echoes br...
As HMBS 2.0 stalls and a 98% buyout rule tightens liquidity, Longbridge Financial’s Tim Wilkinson explains how privat...
This detailed microsoft stock analysis: final verdict breaks down the cloud, AI, and cash flow that power MSFT. Learn...
Emcor Group combines breadth in facilities management and electrical/mechanical contracting with a steady financial p...
Analysts on Thursday issued fresh calls across a raft of names, from Commercial Metals to Wix.com, signaling continue...